(Q45358123)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527850%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Chronic myeloid leukaemia and human immunodeficiency virus (HIV) infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527850%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527850%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Vernon Louw

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527850%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Michael J Webb

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527850%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Christel Pretorius

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527850%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Magdalena F van Jaarsveld

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527850%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

20 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527850%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Hematology

29 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527850%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527850%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527850%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

556-563

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527850%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12185-012-1073-2

29 January 2020

exact match

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1073-2

Chronic myeloid leukemia and HIV-infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1073-2

Chronic myeloid leukemia in a patient with acquired immune deficiency syndrome: complete cytogenetic response with imatinib mesylate: report of a case and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1073-2

Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1073-2

Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1073-2

A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1073-2

Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1073-2

21 January 2018

Adherence to Medication

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1073-2

Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1073-2

Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1073-2

Nonadherence to imatinib adversely affects event free survival in chronic phase chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1073-2

Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1073-2

A systematic review of the associations between dose regimens and medication compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1073-2

Factors influencing adherence to antiretroviral medication in Ilorin, Nigeria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1073-2

Adherence to therapy with oral antineoplastic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1073-2

Exploring chronic myeloid leukemia patients' reasons for not adhering to the oral anticancer drug imatinib as prescribed

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1073-2

Antiretroviral therapy-associated toxicities in the resource-poor world: the challenge of a limited formulary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1073-2

Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1073-2

Results of dasatinib therapy in patients with early chronic-phase chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1073-2

Prognostic factors for patients with chronic myeloid leukaemia in chronic phase treated with imatinib mesylate after failure of interferon alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1073-2

Thrombocytopenia in HIV disease: clinical relevance, physiopathology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1073-2

Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1073-2

Drug hypersensitivity in HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1073-2

21 January 2018

Imatinib-induced DRESS

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1073-2

Phase III, randomized, open-label study of daily imatinib mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: tyrosine kinase inhibitor optimizati

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1073-2

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1073-2

Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1073-2

Changes of immunological profiles in patients with chronic myeloid leukemia in the course of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1073-2

Profound inhibition of antigen-specific T-cell effector functions by dasatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1073-2

Nilotinib hampers the proliferation and function of CD8+ T lymphocytes through inhibition of T cell receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1073-2

Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1073-2

Chronic myeloid leukaemia in South African blacks

21 January 2018

1 reference

12 December 2020

The effects of HIV on hematopoiesis.

1 reference

12 December 2020

Clinical and prognostic features of Nigerians with chronic myeloid leukemia.

1 reference

12 December 2020

Prognostic discrimination in "good-risk" chronic granulocytic leukemia.

1 reference

12 December 2020

Patient nonadherence to medication in inflammatory bowel disease

1 reference

12 December 2020

Pediatric HIV infection and chronic myelogenous leukemia

1 reference

12 December 2020

Chronic myeloid leukaemia in central Africans

1 reference

12 December 2020

Chronic myeloid leukaemia at the Kenyatta National Hospital, Nairobi

1 reference

12 December 2020

Reduction of immunoglobulin levels during imatinib therapy of chronic myeloid leukemia

1 reference

12 December 2020

Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia

1 reference

12 December 2020

Chronic myelogenous leukemia in an HIV-infected patient

1 reference

12 December 2020

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

1 reference

12 December 2020

Improving the cytogenetic response to interferon alpha by zidovudine (AZT) in an HIV-positive chronic myelogenous leukemia patient

1 reference

12 December 2020

Utilization and practice of traditional/complementary/alternative medicine (TM/CAM) in South Africa.

1 reference

12 December 2020

10.1007/S12185-012-1073-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527850%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

29 January 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22527850%20AND%20SRC:MED&resulttype=core&format=json